Rothschild Investment Corp Iveric Bio, Inc. Transaction History

Rothschild Investment Corp

  • $1.19 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 24, 2023
BUY
$18.67 - $24.56 $27,071 - $35,612
1,450 Added 13.49%
12,200 $297,000
Q4 2022

Jan 19, 2023
SELL
$17.24 - $23.95 $47,409 - $65,862
-2,750 Reduced 20.37%
10,750 $230,000
Q3 2022

Oct 21, 2022
BUY
$9.4 - $18.59 $126,900 - $250,965
13,500 New
13,500 $242,000

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Rothschild Investment Corp Portfolio

Follow Rothschild Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email